TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells

Zhengtao Zhou,1,2,* Xiaoqiang Liu,1,2,* Yulei Li,1 Junhua Li,3 Wen Deng,1 Jian Zhong,4 Luyao Chen,1 Yu Li,1 Xiantao Zeng,5 Gongxian Wang,1,2 Jingyu Zhu,3 Bin Fu1,2 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Jiangxi I...

Full description

Bibliographic Details
Main Authors: Zhou Z, Liu X, Li Y, Li J, Deng W, Zhong J, Chen L, Zeng X, Wang G, Zhu J, Fu B
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:OncoTargets and Therapy
Subjects:
emt
Online Access:https://www.dovepress.com/tp53inp2-modulates-epithelial-to-mesenchymal-transition-via-the-gsk-3b-peer-reviewed-article-OTT
id doaj-22b5adaaa63148a9aa1a413ce3d84650
record_format Article
spelling doaj-22b5adaaa63148a9aa1a413ce3d846502020-11-25T02:55:05ZengDove Medical PressOncoTargets and Therapy1178-69302020-09-01Volume 139587959757455TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer CellsZhou ZLiu XLi YLi JDeng WZhong JChen LLi YZeng XWang GZhu JFu BZhengtao Zhou,1,2,* Xiaoqiang Liu,1,2,* Yulei Li,1 Junhua Li,3 Wen Deng,1 Jian Zhong,4 Luyao Chen,1 Yu Li,1 Xiantao Zeng,5 Gongxian Wang,1,2 Jingyu Zhu,3 Bin Fu1,2 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Jiangxi Institute of Urology, Nanchang, People’s Republic of China; 3Department of Urology, Third Hospital of Hangzhou, Hangzhou, People’s Republic of China; 4Department of Surgery, Nankang District Chinese Medicine Hospital, Ganzhou, People’s Republic of China; 5Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin FuDepartment of Urology, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng Street, Nanchang, Jiangxi 330006, People’s Republic of ChinaTel +86 13879103861Email urofubin@sina.comJingyu ZhuDepartment of Urology, Third Hospital of Hangzhou, 38 Westlake Road, Hangzhou, Zhejiang 310009, People’s Republic of ChinaTel +86 571 87827269Email zhujingyu@126.comBackground: The tumor protein p53-inducible nuclear protein 2 (TP53INP2), an autophagy protein, is essential for autophagosome formation. The deregulation of autophagy is associated with multiple human diseases, including cancer. The present study aims to explore the role of TP53INP2 in bladder cancer.Materials and Methods: Quantitative real-time polymerase chain reaction was used to detect the mRNA level. Relative TP53INP2 protein expression was detected by immunohistochemistry and Western blot. The effect of TP53INP2 silencing on the proliferation, migration, and invasion of bladder cancer cells was investigated by CCK-8 detection kit and transwell assay. In addition, transfection and immunofluorescence were performed.Results: In this study, we report that high expression of TP53INP2 is correlated with poor patient survival in bladder cancer. Results demonstrate that the depletion of TP53INP2 inhibits the migration, invasion, and epithelial-to-mesenchymal transition (EMT) of bladder cancer cells. The underlying mechanism was explored. Results show that the TP53INP2 knockdown suppresses EMT by inhibiting the active non-phosphorylated β-catenin and decreasing the Snail1 levels. Furthermore, the glycogen synthase kinase-3 beta (GSK-3β) inhibitor IM-12 abrogates the effect of TP53INP2 silencing. Interestingly, the induction of autophagy partially abrogates the TP53INP2 knockdown-induced decrease in active β-catenin and inhibition of migration and invasion in bladder cancer cells.Conclusion: In summary, our results show that the downregulation of TP53INP2 inhibits EMT via the GSK-3β/β-catenin/Snail1 pathway in bladder cancer. The findings of this study uncover the novel role of TP53INP2 and offer new insights into bladder cancer clinical therapy.Keywords: TP53INP2, β-catenin, Snail1, EMT, bladder cancerhttps://www.dovepress.com/tp53inp2-modulates-epithelial-to-mesenchymal-transition-via-the-gsk-3b-peer-reviewed-article-OTTtp53inp2β-cateninsnail1emtbladder cancer
collection DOAJ
language English
format Article
sources DOAJ
author Zhou Z
Liu X
Li Y
Li J
Deng W
Zhong J
Chen L
Li Y
Zeng X
Wang G
Zhu J
Fu B
spellingShingle Zhou Z
Liu X
Li Y
Li J
Deng W
Zhong J
Chen L
Li Y
Zeng X
Wang G
Zhu J
Fu B
TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
OncoTargets and Therapy
tp53inp2
β-catenin
snail1
emt
bladder cancer
author_facet Zhou Z
Liu X
Li Y
Li J
Deng W
Zhong J
Chen L
Li Y
Zeng X
Wang G
Zhu J
Fu B
author_sort Zhou Z
title TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
title_short TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
title_full TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
title_fullStr TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
title_full_unstemmed TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
title_sort tp53inp2 modulates epithelial-to-mesenchymal transition via the gsk-3β/β-catenin/snail1 pathway in bladder cancer cells
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2020-09-01
description Zhengtao Zhou,1,2,* Xiaoqiang Liu,1,2,* Yulei Li,1 Junhua Li,3 Wen Deng,1 Jian Zhong,4 Luyao Chen,1 Yu Li,1 Xiantao Zeng,5 Gongxian Wang,1,2 Jingyu Zhu,3 Bin Fu1,2 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Jiangxi Institute of Urology, Nanchang, People’s Republic of China; 3Department of Urology, Third Hospital of Hangzhou, Hangzhou, People’s Republic of China; 4Department of Surgery, Nankang District Chinese Medicine Hospital, Ganzhou, People’s Republic of China; 5Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin FuDepartment of Urology, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng Street, Nanchang, Jiangxi 330006, People’s Republic of ChinaTel +86 13879103861Email urofubin@sina.comJingyu ZhuDepartment of Urology, Third Hospital of Hangzhou, 38 Westlake Road, Hangzhou, Zhejiang 310009, People’s Republic of ChinaTel +86 571 87827269Email zhujingyu@126.comBackground: The tumor protein p53-inducible nuclear protein 2 (TP53INP2), an autophagy protein, is essential for autophagosome formation. The deregulation of autophagy is associated with multiple human diseases, including cancer. The present study aims to explore the role of TP53INP2 in bladder cancer.Materials and Methods: Quantitative real-time polymerase chain reaction was used to detect the mRNA level. Relative TP53INP2 protein expression was detected by immunohistochemistry and Western blot. The effect of TP53INP2 silencing on the proliferation, migration, and invasion of bladder cancer cells was investigated by CCK-8 detection kit and transwell assay. In addition, transfection and immunofluorescence were performed.Results: In this study, we report that high expression of TP53INP2 is correlated with poor patient survival in bladder cancer. Results demonstrate that the depletion of TP53INP2 inhibits the migration, invasion, and epithelial-to-mesenchymal transition (EMT) of bladder cancer cells. The underlying mechanism was explored. Results show that the TP53INP2 knockdown suppresses EMT by inhibiting the active non-phosphorylated β-catenin and decreasing the Snail1 levels. Furthermore, the glycogen synthase kinase-3 beta (GSK-3β) inhibitor IM-12 abrogates the effect of TP53INP2 silencing. Interestingly, the induction of autophagy partially abrogates the TP53INP2 knockdown-induced decrease in active β-catenin and inhibition of migration and invasion in bladder cancer cells.Conclusion: In summary, our results show that the downregulation of TP53INP2 inhibits EMT via the GSK-3β/β-catenin/Snail1 pathway in bladder cancer. The findings of this study uncover the novel role of TP53INP2 and offer new insights into bladder cancer clinical therapy.Keywords: TP53INP2, β-catenin, Snail1, EMT, bladder cancer
topic tp53inp2
β-catenin
snail1
emt
bladder cancer
url https://www.dovepress.com/tp53inp2-modulates-epithelial-to-mesenchymal-transition-via-the-gsk-3b-peer-reviewed-article-OTT
work_keys_str_mv AT zhouz tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT liux tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT liy tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT lij tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT dengw tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT zhongj tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT chenl tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT liy tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT zengx tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT wangg tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT zhuj tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
AT fub tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells
_version_ 1724718408123023360